It takes stat people just a few days to review for topline. You are inferring another layer of delay bureaucracy prior to topline. A layer Dr. Bosch did not infer when he spoke at ASCO in June 2019. For most companies, substantial additional delay is material information to investors.
I'm not agreeing w you regarding topline data. Once unblinded all you need is a calculator for TLD. IMHO. Doing all the sub-analysis that will be presented at a conference or to the Agencies, now that will take time.